Schultes Birgit C (CIK 0002051419)

Latest company ownership

NTLA - Intellia Therapeutics, Inc.

Role: EVP, Chief Scientific Officer

Shares held

105,184

Last filed at

Oct 3, 2025

Confidence Score

51.9

2025Q4

Confidence Score History

2025Q4 2025Q4

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Oct 1, 2025	Oct 3, 2025	Intellia Therapeutics, Inc.	EVP, Chief Scientific Officer	Sell	52.5	-31	-0.03%	✗	$538.8